封面
市场调查报告书
商品编码
1739611

全球神经科学市场:市场规模(按组件、技术、最终用户和地区划分)、未来预测

Global Neuroscience Market Size by Component, By Technology, By End-User, By Geographic Scope and Forecast

出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

神经科学市场规模与预测

2024 年神经科学市场规模价值 284.4 亿美元,预计到 2032 年将达到 395.9 亿美元,2026 年至 2032 年的复合年增长率为 4.22%。

  • 神经科学是一门研究神经系统的学科,包括大脑、脊髓和神经网络,以及这些结构如何控制行为、认知和身体功能,结合了生物学、心理学和医学的元素。
  • 神经科学是一门研究神经系统的学科,旨在更好地理解大脑功能、行为和神经系统疾病,并致力于开发治疗方法阿兹海默症、忧郁症和癫痫的方法。它结合了生物学、心理学和技术,旨在改善心理健康和认知能力。
  • 神经科学的未来将改变心理健康,改进脑机接口,并推动认知疗法。神经影像和人工智慧的进步将实现个人化治疗、更早的疾病检测以及提升人类表现的脑机介面。

全球神经科学市场动态

影响全球神经科学市场的关键市场动态是:

关键市场驱动因素

  • 脑部疾病负担日益加重:阿兹海默症神经病变正成为一种流行病。根据美国国立卫生研究院的数据,2021年,65岁及以上的美国人中,有620万人患有阿兹海默症,预计到2050年,这一数字将上升到1,270万人。盛行率的上升推动了对诊断工具、治疗方法和研究的需求。
  • 神经科学与技术的突破:脑部造影、基因编辑(CRISPR)和脑机介面的进步正在改变游戏规则。美国国立卫生研究院 (NIH) 强调,FDA 最近核准了AI 软体,用于增强 MRI 扫描中脑萎缩的评估。这些进步将为新技术和药物开闢市场。
  • 老年人口不断增加:世界老年人口正在迅速增长,导致与年龄相关的神经系统疾病(如阿兹海默症和帕金森氏症)老龄化,这反过来又增加了对诊断工具和治疗方案的需求。

主要挑战

  • 伦理问题:神经科学研究引发了隐私、知情同意以及资料潜在用途等问题。平衡科学进步与伦理考量仍是一项挑战。
  • 高成本且获取途径有限:脑成像设备和训练有素的人员价格昂贵,限制了它们的普及并阻碍了它们在研究和开发中的广泛应用。
  • 资料解释与综合:神经科学资料的分析很复杂,需要专业知识,将研究结果与传统研究方法结合以提供更全面的图景也可能有问题。
  • 标准化和可重复性:研究方法和数据分析技术的标准化对于确保结果可重复至关重要,尤其是在临床应用中。

主要趋势:

  • 神经技术的进步:神经技术的进步包括非侵入性脑部成像技术(fMRI、EEG)、脑机介面(BCI)和用于精确激活大脑的光遗传学,这些技术为新的诊断工具和治疗方法提供了机会。
  • 人们对心理健康的兴趣日益浓厚:忧郁症和焦虑症等精神疾病的盛行率不断上升,推动了对基于神经科学的治疗的需求。测量大脑活动的可穿戴设备和数位疗法正日益普及。
  • 个人化医疗:研究大脑个体差异的能力拥有巨大的潜力。这项技术涉及根据患者的独特情况,为阿兹海默症和帕金森氏症等神经系统疾病治疗方法。
  • 人工智慧与巨量资料的融合:人工智慧正在改变神经科学领域的数据分析。强大的演算法有助于理解复杂的脑数据,从而加快诊断速度、开发治疗方法并实现个人化医疗。

目录

第一章 引言

  • 市场定义
  • 细分市场
  • 分析方法

第二章执行摘要

  • 主要发现
  • 市场概览
  • 市集亮点

第三章市场概述

  • 市场规模和成长潜力
  • 市场趋势
  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析

第四章 神经科学市场(依组成部分)

  • 装置
  • 软体
  • 服务

第五章 神经科学市场(依技术)

  • 全脑影像
  • 神经显微镜
  • 电生理学
  • 光电分析
  • 动物行为分析
  • 神经功能分析

第六章 神经科学市场(依最终使用者)

  • 医院
  • 诊断实验室
  • 学术和研究机构

第七章区域分析

  • 北美洲
  • 美国
  • 加拿大
  • 墨西哥
  • 欧洲
  • 英国
  • 德国
  • 法国
  • 义大利
  • 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 智利
  • 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国

第八章市场动态

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 感染疾病 -19对市场的影响

第九章 竞争态势

  • 主要企业
  • 市场占有率分析

第十章 公司简介

  • NEURALINK
  • Kernel
  • BrainCo.Inc.
  • MindMaze
  • Paradromics
  • NeuroPro
  • NeuroSky
  • EMOTIV.Inc.
  • Cercare Medical A/S
  • Plexon.Inc.
  • Noldus Information Technology BV
  • Femtonics Ltd.
  • Neuralynx.Inc.
  • Neurable.Inc.
  • Bitbrain Technologies.

第十一章 市场展望与机会

  • 新兴技术
  • 未来市场趋势
  • 投资机会

第十二章 附录

  • 简称列表
  • 来源和参考文献
简介目录
Product Code: 60493

Neuroscience Market Size And Forecast

Neuroscience Market size was valued at USD 28.44 Billion in 2024 and is projected to reach 39.59 USD Billion by 2032 growing at a CAGR of 4.22% from 2026 to 2032.

  • Neuroscience is the study of the nervous system, which includes the brain, spinal cord, and neural networks. It investigates how these structures regulate behaviour, cognition and body functions, combining elements of biology, psychology and medicine.
  • Neuroscience is the study of the nervous system in order to better understand brain function, behaviour and neurological illnesses, with the goal of developing treatments for conditions such as Alzheimer's, depression, and epilepsy. It combines biology, psychology and technology to enhance mental health and cognitive abilities.
  • Future neuroscience will transform mental health, improve brain-machine interfaces and advance cognitive therapies. Advances in neuroimaging and artificial intelligence will enable individualized treatments, early disease detection and brain-computer interfaces to boost human capacities.

Global Neuroscience Market Dynamics

The key market dynamics that are shaping the global neuroscience market include:

Key Market Drivers:

  • Rising Burden of Brain Disorders: Neurological disorders such as Alzheimer's are becoming more prevalent. According to the NIH, 6.2 million Americans over the age of 65 have Alzheimer's in 2021, with the figure expected to rise to 12.7 million by 2050. This growing prevalence drives need for diagnostic tools, therapies and research.
  • Breakthroughs in Neuroscience and Technology: Advances in brain imaging, gene editing (CRISPR) and brain-computer interfaces are changing the game. The NIH emphasizes the FDA's recent approval of AI software for enhanced brain atrophy assessment in MRI scans. These advancements open up a market for new technologies and medicines.
  • Growing Geriatric Population: The worldwide geriatric population is quickly expanding, resulting in an increase in age-related neurological disorders such as Alzheimer's and Parkinson's. This drives the demand for diagnostic tools and treatment choices.

Key Challenges:

  • Ethical Concerns: Neuroscience research poses issues of privacy, informed consent, and potential data exploitation. Balancing scientific advances with ethical considerations remains a challenge.
  • High Cost and Limited Access: Brain imaging equipment and trained workers are costly. This reduces accessibility and prevents wider usage in research and development.
  • Data Interpretation and Integration: Analysing neuroscience data is complex and requires specialist expertise. Another problem is integrating findings with traditional research methods to provide a more comprehensive picture.
  • Standardization and Reproducibility: Standardizing research techniques and data analysis methodologies is critical for ensuring that results can be replicated. This is particularly essential in clinical applications.

Key Trends:

  • Advancement in Neurotechnology: Neurotechnology advancements include non-invasive brain imaging techniques (fMRI, EEG), brain-computer interfaces (BCIs) and optogenetics for precise brain activation. This creates opportunities for novel diagnostic tools and therapeutic approaches.
  • Growing Interest in Mental Health: The increasing prevalence of mental health illnesses such as depression and anxiety is driving demand for neuroscience-based therapies. Wearable gadgets for measuring brain activity and digital therapies are gaining popularity.
  • Personalized Medicine: The ability to study individual brain variances has enormous potential. This technique involves adapting therapies for neurological illnesses such as Alzheimer's and Parkinson's to unique patient profiles.
  • AI and Big Data Integration: Artificial intelligence is transforming data analysis in neuroscience. Powerful algorithms can help comprehend complex brain data, resulting in faster diagnosis, therapy development, and personalized medicine methods.

Global Neuroscience Market Regional Analysis

Here is a more detailed regional analysis of the global neuroscience market:

North America:

  • According to Verified Market Research, North America is expected to dominate the global neuroscience market.
  • Strong government financing supports research and development. For example, the National Institutes of Health (NIH) in the United States has committed more than $4 billion to neurological research in 2021.
  • This strong financial backing fosters a flourishing research environment that includes premier universities and research institutions.
  • The rising incidence of neurological illnesses in North America drives up market demand.
  • The growing disease burden emphasizes the need for novel diagnostic technologies, therapies, and preventative measures. These elements, combined, strengthen North America's leading position in the neuroscience sector.

Asia Pacific:

  • According to Verified Market Research, Asia Pacific is fastest growing region in global neuroscience market.
  • The Asia-Pacific region is the fastest-growing in the neuroscience market, driven by several factors. Increasing healthcare spending and increased knowledge of neurological illnesses are major influences.
  • Furthermore, advances in medical technology and infrastructure, combined with supportive government measures are driving market expansion.
  • The region is also seeing an increase in research activity and collaborations between local and international institutions. Countries such as China, Japan, and India are leading the way, investing extensively in neuroscience research and development. This increasing trajectory is further assisted by an aging population, which increases the prevalence of neurological diseases.

Global Neuroscience Market: Segmentation Analysis

The Global Neuroscience Market is segmented based on Component, Technology, End-User and Geography.

Global Neuroscience Market, By Component

  • Instrument
  • Software* Services

Based on Component, the Global Neuroscience Market is separated into Instrument, Software, and Services. The instrument sector dominates the worldwide neuroscience market, owing to increasing demand for improved neuroimaging equipment, electrophysiology instruments and other cutting-edge tools for use in research and clinical settings. These tools are critical for correctly diagnosing, monitoring, and treating neurological diseases.

Global Neuroscience Market, By Technology

  • Whole Brain Imaging
  • Neuro-microscopy
  • Electrophysiology
  • Neurophotonics Analysis
  • Animal Behavior Analysis
  • Neuro-functional Analysis

Based on Technology, Global Neuroscience Market is divided into Whole Brain Imaging, Neuro-microscopy, Electrophysiology, Neurophotonics Analysis, Animal Behavior Analysis, Neuro-functional Analysis. Whole Brain Imaging dominates the worldwide neuroscience market due to its comprehensive capacity to visualize and map brain activity and structure. It is the leading technology in the neuroscience field due to its applications in diagnosing neurological disorders, conducting research on brain functions and advances in imaging technologies.

Global Neuroscience Market, By End-User

  • Hospitals
  • Diagnostic Laboratories
  • Academic & Research Institutions

Based on End-User, Global Neuroscience Market is divided into Hospitals, Diagnostic Laboratories, Academic & Research Institutions. In the global neuroscience market, hospitals are the key end-users. They are critical to providing sophisticated neurological therapies and performing significant research. Their established infrastructure, access to cutting-edge technology, and large patient influx position them centrally in the market's growth and development.

Global Neuroscience Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Based on the Geography, the Global Neuroscience Market is divided into North America, Europe, Asia Pacific and Rest of the World. North America leads the worldwide neuroscience market, owing to significant investments and advanced healthcare infrastructure. The Asia-Pacific area is the fastest expanding, thanks to rising healthcare spending, technological improvements and a growing understanding of neurological illnesses.

Key Players

  • The Global Neuroscience Market study report will provide valuable insight with an emphasis on the global market. The major players in the market are NEURALINK, Kernel, BrainCo, Inc., MindMaze, Paradromics, NeuroPro, NeuroSky, EMOTIV, Inc., Cercare Medical A/S, Plexon, Inc., Noldus Information Technology B.V., Femtonics Ltd., Neuralynx, Inc., Neurable, Inc., Bitbrain Technologies.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

  • Global Neuroscience Market Recent Developments
  • In February 2022, NeuroNexus Technologies introduced the NeuroNexus Summa Framework. The solution was meant to this tool enables expert electrophysiologists and life science researchers to effortlessly integrate electrical signals from biological cells and tissues into their research workflows.
  • Analyst's Take
  • The Neuroscience Market is experiencing significant growth driven by factors such as increasing prevalence of neurological disorders, advancements in neuroimaging and diagnostic technologies, and rising investments in neuroscience research. With the aging population and growing awareness about mental health, there is a heightened demand for innovative therapies and interventions for conditions like Alzheimer's disease, Parkinson's disease, depression, and epilepsy. Moreover, collaborations between academia, industry, and government organizations are fostering research initiatives and driving the development of novel treatments and technologies in the neuroscience field. However, challenges such as high development costs, regulatory hurdles, and ethical considerations regarding neuroscientific research remain prominent. Overall, the Neuroscience Market presents lucrative opportunities for stakeholders across the healthcare sector, including pharmaceutical companies, medical device manufacturers, research institutions, and healthcare providers, to address unmet medical needs and improve patient outcomes.

TABLE OF CONTENTS

1. INTRODUCTION

  • Market Definition
  • Market Segmentation
  • Research Methodology

2. Executive Summary

  • Key Findings
  • Market Overview
  • Market Highlights

3. Market Overview

  • Market Size and Growth Potential
  • Market Trends
  • Market Drivers
  • Market Restraints
  • Market Opportunities
  • Porter's Five Forces Analysis

4. Neuroscience Market, By Component

  • Instrument
  • Software
  • Services

5. Neuroscience Market, By Technology

  • Whole Brain Imaging
  • Neuro-microscopy
  • Electrophysiology
  • Neurophotonics Analysis
  • Animal Behavior Analysis
  • Neuro-functional Analysis

6. Neuroscience Market, By End-User

  • Hospitals
  • Diagnostic Laboratories
  • Academic & Research Institutions

7. Regional Analysis

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • Latin America
  • Brazil
  • Argentina
  • Chile
  • Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

8. Market Dynamics

  • Market Drivers
  • Market Restraints
  • Market Opportunities
  • Impact of COVID-19 on the Market

9. Competitive Landscape

  • Key Players
  • Market Share Analysis

10. Company Profiles

  • NEURALINK
  • Kernel
  • BrainCo.Inc.
  • MindMaze
  • Paradromics
  • NeuroPro
  • NeuroSky
  • EMOTIV.Inc.
  • Cercare Medical A/S
  • Plexon.Inc.
  • Noldus Information Technology B.V.
  • Femtonics Ltd.
  • Neuralynx.Inc.
  • Neurable.Inc.
  • Bitbrain Technologies.

11. Market Outlook and Opportunities

  • Emerging Technologies
  • Future Market Trends
  • Investment Opportunities

12. Appendix

  • List of Abbreviations
  • Sources and References